Alain G Verstraete Selected Research

Piperacillin

9/2019	Corrigendum to "Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients". [Int J Antimicrob Agents 51 (2018) 594-600].
8/2019	Corrigendum to 'Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients' [International Journal of Antimicrobial Agents 51 (2018) 594-600].
1/2019	Measuring Unbound Versus Total Piperacillin Concentrations in Plasma of Critically Ill Patients: Methodological Issues and Relevance.
4/2018	Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients.
1/2017	Dose optimization of piperacillin/tazobactam in critically ill children.
5/2014	Does consistent piperacillin dosing result in consistent therapeutic concentrations in critically ill patients? A longitudinal study over an entire antibiotic course.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alain G Verstraete Research Topics

Disease

15	Critical Illness (Critically Ill) 01/2022 - 11/2013
2	Infections 09/2021 - 03/2019
1	COVID-19 04/2022
1	Dihydropyrimidine Dehydrogenase Deficiency 04/2022
1	Neoplasms (Cancer) 05/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2021
1	Temporal Lobe Epilepsy 01/2021
1	Seizures (Absence Seizure) 01/2021
1	Cystic Fibrosis (Mucoviscidosis) 01/2018
1	Body Weight (Weight, Body) 11/2015
1	Hemolysis 04/2010
1	Poisoning 01/2005
1	Coma (Comas) 12/2003

Drug/Important Bio-Agent (IBA)

7	Anti-Bacterial Agents (Antibiotics)IBA 04/2022 - 08/2015
6	Piperacillin FDA LinkGeneric 09/2019 - 05/2014
4	LactamsIBA 01/2022 - 08/2015
3	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 04/2020 - 01/2017
3	Meropenem (Merrem)FDA LinkGeneric 04/2020 - 01/2019
2	Pharmaceutical PreparationsIBA 05/2021 - 12/2003
2	Heparin (Liquaemin)FDA LinkGeneric 05/2021 - 01/2019
2	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 11/2015 - 11/2013
1	dihydrouracilIBA 04/2022
1	TegafurIBA 04/2022
1	Capecitabine (Xeloda)FDA Link 04/2022
1	Fluorouracil (Carac)FDA LinkGeneric 04/2022
1	UracilIBA 04/2022
1	beta-LactamsIBA 01/2022
1	beta Lactam AntibioticsIBA 09/2021
1	ibrutinibIBA 05/2021
1	midostaurinIBA 05/2021
1	bosutinibIBA 05/2021
1	nilotinib FDA Link 05/2021
1	ponatinibIBA 05/2021
1	gilteritinibIBA 05/2021
1	Imatinib Mesylate (Gleevec)FDA Link 05/2021
1	Dasatinib (BMS 354825)FDA Link 05/2021
1	Tyrosine Kinase InhibitorsIBA 05/2021
1	Edetic Acid (EDTA)FDA Link 05/2021
1	Kainic Acid (Kainate)IBA 01/2021
1	Clozapine (Clozaril)FDA LinkGeneric 01/2021
1	Anti-Infective Agents (Microbicides)IBA 08/2019
1	TeicoplaninIBA 03/2019
1	Blood Proteins (Serum Proteins)IBA 03/2019
1	Tazobactam FDA LinkGeneric 01/2017
1	Cefuroxime (Zinacef)FDA LinkGeneric 10/2014
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 11/2013
1	Amoxicillin (Wymox)FDA LinkGeneric 11/2013
1	Hemoglobins (Hemoglobin)IBA 04/2010
1	HemopexinIBA 04/2010
1	HaptoglobinsIBA 04/2010
1	Scopolamine (Hyoscine)FDA Link 01/2005
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2005
1	butyl bromideIBA 01/2005
1	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 12/2003
1	Illicit Drugs (Recreational Drugs)IBA 12/2003

Therapy/Procedure

5	Therapeutics 01/2022 - 08/2015
1	Critical Care (Surgical Intensive Care) 04/2020